Klein B - Search Results

1

Elevated pretreatment levels of soluble CD8 and Beta-2-microglobulin as indicators of relapse in breast-cancer patients.

Klein B, Levin I, Lurie H, Nyska A, Shapira J, Kravits M, Klein T. Klein B, et al. Among authors: klein t. Int J Oncol. 1994 Feb;4(2):471-4. doi: 10.3892/ijo.4.2.471. Int J Oncol. 1994. PMID: 21566948

2

Correlation between tps and cea in patients with colorectal-cancer.

Klein B, Levin I, Michaeli M, Wolfson L, Gal R, Shapira I, Kfir B, Rakovsky E, Klein T. Klein B, et al. Among authors: klein t. Int J Oncol. 1995 Aug;7(2):267-71. Int J Oncol. 1995. PMID: 21552835

3

Soluble C-erbb-2 (p185) in breast-cancer patients in relation to prognosis.

Klein B, Levin I, Kfir B, Marinski R, Rakowski E, Shapira J, Weil R, Mishaeli M, Klein T. Klein B, et al. Among authors: klein t. Oncol Rep. 1995 Sep;2(5):759-61. doi: 10.3892/or.2.5.759. Oncol Rep. 1995. PMID: 21597811

4

Serum intracellular adhesion molecule-1 (sicam-1) and soluble hla class-1 antigens in breast-cancer patients in relation to tumor burden.

Levin I, Klein T, Shapira Y, Lurie H, Kfir B, Narinsky R, Lehmann J, Klein B. Levin I, et al. Among authors: klein t, klein b. Oncol Rep. 1994 Jan;1(1):217-20. doi: 10.3892/or.1.1.217. Oncol Rep. 1994. PMID: 21607340

5

The significance of soluble interleukin-2, soluble interleukin-2 receptors, soluble ICAM-1 and beta 2-microglobulin in breast cancer patients.

Klein B, Levin I, Kfir B, Mishaeli M, Shapira J, Klein T. Klein B, et al. Among authors: klein t. Tumour Biol. 1995;16(5):290-6. Tumour Biol. 1995. PMID: 7652467

6

Correlation between tumour and serum beta 2m expression in patients with breast cancer.

Klein T, Levin I, Niska A, Koren R, Gal R, Schachter J, Kfir B, Narinski R, Warchaizer S, Klein B. Klein T, et al. Among authors: klein b. Eur J Immunogenet. 1996 Dec;23(6):417-23. doi: 10.1111/j.1744-313x.1996.tb00132.x. Eur J Immunogenet. 1996. PMID: 8971539

7

HLA class I antigen expression in human solid tumors.

Klein B, Levin I, Klein T. Klein B, et al. Among authors: klein t. Isr J Med Sci. 1996 Dec;32(12):1238-43. Isr J Med Sci. 1996. PMID: 9007163 Review.

8

HLA class I and advanced melanoma in Israeli Jews.

Schachter J, Klein T, Klein B, Adler A. Schachter J, et al. Among authors: klein t, klein b. Int J Oncol. 1997 Mar;10(3):645-8. doi: 10.3892/ijo.10.3.645. Int J Oncol. 1997. PMID: 21533427

9

Soluble histocompatibility antigen class I in breast cancer patients in relation to tumor burden.

Klein B, Klein T, Figer A, Bleiberg M, Shapira J, Loven D, Livni E, Lurie H, Niska A. Klein B, et al. Among authors: klein t. Cancer. 1991 May 1;67(9):2295-9. doi: 10.1002/1097-0142(19910501)67:9<2295::aid-cncr2820670915>3.0.co;2-t. Cancer. 1991. PMID: 2013037

10

The expression of HLA class I antigen in prostate cancer in relation to tumor differentiation and patient survival.

Levin I, Klein T, Kuperman O, Segal S, Shapira J, Gal R, Hart Y, Klein B. Levin I, et al. Among authors: klein t, klein b. Cancer Detect Prev. 1994;18(6):443-5. Cancer Detect Prev. 1994. PMID: 7867017

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,757 results

Search Page

Filters